Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Tropea

Showing results (71-80 of 115) with videos related to

Pageof 12
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|April 13, 2024
GPNMB Biomarker Levels in GBA1 Carriers with Lewy Body DisordersEliza M Brody, Yunji Seo, EunRan Suh, et al.
Annals of Neurology|April 27, 2026
Insights Gained From the PPMI Brain Donation ProgramTatiana Foroud, Laura E A Heathers, Syed Bukhari, et al.
Annals of Neurology|April 12, 2019
TMEM106B Effect on cognition in Parkinson disease and frontotemporal dementiaThomas F Tropea, Jordan Mak, Michael H Guo, et al.
Annals of Neurology|May 6, 2026
Biologic Frameworks for Synucleinopathies: Contributions of the Parkinson's Progression Markers InitiativeLana M Chahine, Roy N Alcalay, Ethan G Brown, et al.
Annals of Neurology|May 20, 2022
Plasma MIA, CRP, and Albumin Predict Cognitive Decline in Parkinson's DiseaseJunchao Shen, Noor Amari, Rebecca Zack, et al.
Ebiomedicine|July 22, 2022
Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing ageLeah Zuroff, Ayman Rezk, Koji Shinoda, et al.
Medrxiv : the Preprint Server for Health Sciences|January 27, 2025
Tau Burden is Best Captured by Magnitude and Extent: Tau-MaX as a Measure of Global TauChristopher A Brown, Sandhitsu R Das, Katheryn A Q Cousins, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 4, 2025
Tau burden is best captured by magnitude and extent: Tau-MaX as a measure of global tauChristopher A Brown, Sandhitsu R Das, Katheryn A Q Cousins, et al.
Annals of Clinical and Translational Neurology|December 15, 2022
Plasma phosphorylated tau181 predicts cognitive and functional declineThomas F Tropea, Teresa Waligorska, Sharon X Xie, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 22, 2024
Pathologic and cognitive correlates of plasma biomarkers in neurodegenerative diseaseKatheryn A Q Cousins, Jeffrey S Phillips, Sandhitsu R Das, et al.
Pageof 12

Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
Movement Disorders : Official Journal of the Movement Disorder Society|April 13, 2024
GPNMB Biomarker Levels in GBA1 Carriers with Lewy Body DisordersEliza M Brody, Yunji Seo, EunRan Suh, et al.
Annals of Neurology|April 27, 2026
Insights Gained From the PPMI Brain Donation ProgramTatiana Foroud, Laura E A Heathers, Syed Bukhari, et al.
Annals of Neurology|April 12, 2019
TMEM106B Effect on cognition in Parkinson disease and frontotemporal dementiaThomas F Tropea, Jordan Mak, Michael H Guo, et al.
Annals of Neurology|May 6, 2026
Biologic Frameworks for Synucleinopathies: Contributions of the Parkinson's Progression Markers InitiativeLana M Chahine, Roy N Alcalay, Ethan G Brown, et al.
Annals of Neurology|May 20, 2022
Plasma MIA, CRP, and Albumin Predict Cognitive Decline in Parkinson's DiseaseJunchao Shen, Noor Amari, Rebecca Zack, et al.
Ebiomedicine|July 22, 2022
Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing ageLeah Zuroff, Ayman Rezk, Koji Shinoda, et al.
Medrxiv : the Preprint Server for Health Sciences|January 27, 2025
Tau Burden is Best Captured by Magnitude and Extent: Tau-MaX as a Measure of Global TauChristopher A Brown, Sandhitsu R Das, Katheryn A Q Cousins, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 4, 2025
Tau burden is best captured by magnitude and extent: Tau-MaX as a measure of global tauChristopher A Brown, Sandhitsu R Das, Katheryn A Q Cousins, et al.
Annals of Clinical and Translational Neurology|December 15, 2022
Plasma phosphorylated tau181 predicts cognitive and functional declineThomas F Tropea, Teresa Waligorska, Sharon X Xie, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 22, 2024
Pathologic and cognitive correlates of plasma biomarkers in neurodegenerative diseaseKatheryn A Q Cousins, Jeffrey S Phillips, Sandhitsu R Das, et al.
Pageof 12